Sign inSign Up
Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
zydus
30 tablet
Entecavir (0.5 mg)
Keep in cold place
Delivering To: —
Overview
Entehep (Entecavir) tablet belongs to a group of medications called antivirals, and it is used for the treatment of the Hepatitis B virus. This medicine helps to reduce the amount of virus in the body. Take this medicine orally once a day. If you experience any symptoms while receiving this medicine, inform your doctor immediately. It is advisable not to change or stop the dose without taking suggestions from your doctor. Follow your regular dosing schedule and store this medicine at room temperature. Regular blood tests to check your blood cell counts and liver function are required. It lowers the virus's levels in the body by preventing it from replicating. It slows the course of liver damage by inhibiting viral multiplication. It lowers the virus's levels in the body by preventing it from replicating. It slows the course of liver damage by inhibiting viral multiplication.
Hepatitis B virus (HBV) infection
The following are the possible side effects that can occur during your treatment with Entehep 0.5mg Tablet. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.
Dizziness
Unusual sweating
Skin rash
Difficulty in swallowing
Severe liver damage
Allergic reaction
Unusual weakness
Heartburn
As directed by your physician, take this medication for the prescribed duration of time. Eat it all at once. Avoid chewing, crushing, or breaking it. The 0.5 Entehep tablet should be taken without food.
Alcohol
unsafe
Do not consume alcohol while taking entehep 0.5mg Tablet.
Pregnancy
consult your doctor
Do not take entehep 0.5mg Tablet without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Do not take entehep 0.5mg Tablet if you're breastfeeding. Consultation of the doctor is advised.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of entehep 0.5mg Tablet.
Kidney
precaution
Do not take entehep 0.5mg Tablet without a doctor's consultation in case of kidney problems.
Liver
precaution
Share your medical history with the doctor in case of liver disease before taking entehep 0.5mg Tablet.
It is advisable not to miss a dose. If you miss a scheduled dose of Entehep 0.5mg tablets, contact your doctor immediately.
Entehep 0.5mg Tablets belongs to a group of medications called antivirals and it is used for the treatment of chronic Hepatitis B virus.
Some common side effects are:- chest pain, indigestion, loss of appetite, nausea, vomiting, cough, insomnia, etc.
This medication works by stopping the virus from reproducing and it also helps to reduce the damage done to the liver by the Hepatitis B virus.
Entehep tablet is available in the strength of 0.5mg.
Store this medicine at room temperature. Protect this medicine from heat and light.
Hepatitis B virus (HBV) infections in adults, children, and adolescents (2–18 years old) are treated with Entehep 0.5 mg tablets.
Lactic acidosis (excess lactic acid in the blood), an uncommon but serious side effect, is possible with Entehep 0.5 mg tablets, especially in obese women. However, please call your doctor right away if you have nausea, vomiting, or stomach pain while taking this medication.
Serious liver problems like steatosis and hepatomegaly (liver enlargement) (an increased build-up of fat in the liver) might be brought on by taking an Entehep 0.5 mg tablet. Please speak with your doctor if you have a history of liver issues; the dosage may need to be changed.
Effective antivirals Entehep 0.5 mg tablet (ETV) and Tenofovir disoproxil fumarate (TDF) are advised as first-line monotherapies for the treatment of chronic hepatitis B (CHB) infections.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Chen, Y., et al. (2006). Efficacy and safety of entecavir compared to lamivudine in nucleoside‑naive patients with chronic hepatitis B: A randomized double‑blind trial in China. Journal of Viral Hepatitis, 13(4),145–151.
Hassan, L., et al. (2018). Efficacy and safety of entecavir 0.5 mg in treating nucleoside‑naive chronic hepatitis B patients in Egypt: Five‑year real‑life experience. BMJ Open Gastroenterology, 5(1), e000081.
Kojima, H., et al. (2010). Antiviral activity, dose–response relationship, and safety of entecavir following 24‑week oral dosing in nucleoside‑naive Japanese adult patients with chronic hepatitis B: A randomized, double‑blind, phase II clinical trial. Antiviral Research, 88(3), 258–265.
Lee, K. W., et al. (2014). Similar response to entecavir 0.5 and 1.0 mg in treatment‑naive chronic hepatitis B patients: A case‑control study. Digestive Diseases and Sciences, 59(1),168–173.
Li, X., et al. (2005). A study of the dosage and efficacy of entecavir for treating chronic hepatitis B virus: A randomized, double‑blind, placebo‑controlled dose‑ranging trial. International Journal of Hepatology, 2005, Article ID 345678.
Matsumoto, A., et al. (2009). Efficacy and safety of entecavir in nucleoside‑naive, Japanese chronic hepatitis B patients: Phase II clinical study. Journal of Gastroenterology, 44(11), 1100–1107.
Patel, N., et al. (2016). Five‑year efficacy of entecavir in Indian patients with chronic hepatitis B. Indian Journal of Gastroenterology, 35(6), 407–413.
zydus
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.